Beam Therapeutics Short % of float
What is the Short % of float of Beam Therapeutics?
The Short % of float of Beam Therapeutics Inc. is 21.41%
What is the definition of Short % of float?
Short percentage of float is the amount of shares being shorted compared to the float expressed as a percentage.
= short interest / float shares
Short percentage of float, or short interest ratio, is calculated by taking the total amount of shares shorted and dividing it by the total amount of shares available for trade. It is an indirect metric of investor sentiment. When short percentage of float is high, above 40%, it implies company investors hope shares will decline in value. The percentage is used by both fundamental and technical traders to identify trends. The short percentage of float can also be calculated for entire exchanges to determine the sentiment of the market as a whole. If it is high of around five or greater for an exchange, this can be taken as a bearish signal, and vice versa.
Short % of float of companies in the Health Care sector on NASDAQ compared to Beam Therapeutics
What does Beam Therapeutics do?
Beam Therapeutics Inc., a biotechnology company, develops precision genetic medicines for patients suffering from serious diseases in the United States. The company is developing BEAM-101 for the treatment of sickle cell disease and beta thalassemia; BEAM-102 for the treatment of sickle cell disease; and BEAM-201, an allogeneic chimeric antigen receptor T cell for the treatment of relapsed/refractory T-cell acute lymphoblastic leukemia. It also develops therapies for alpha-1 antitrypsin deficiency and glycogen storage disorder 1a; and therapies for ocular and central nervous system disorders. The company has a strategic alliance with Boston Children's Hospital; a research and clinical collaboration agreement with Magenta Therapeutics, Inc.; and a research collaboration with the Institute of Molecular and Clinical Ophthalmology Basel. It also has a research collaboration with Apellis Pharmaceuticals, Inc. to apply base editing technology for discovering new treatments for complement-driven diseases. Beam Therapeutics Inc. was incorporated in 2017 and is headquartered in Cambridge, Massachusetts.
Companies with short % of float similar to Beam Therapeutics
- MyoKardia has Short % of float of 21.05%
- Smiledirectclub Inc has Short % of float of 21.06%
- Kirkland`s Inc has Short % of float of 21.06%
- Spark Inc has Short % of float of 21.09%
- Pioneer Services has Short % of float of 21.24%
- MSG Networks Inc has Short % of float of 21.26%
- Beam Therapeutics has Short % of float of 21.41%
- Big 5 Sporting Goods Corp has Short % of float of 21.43%
- Bonanza Creek Inc has Short % of float of 21.47%
- Luminar Technologies Inc has Short % of float of 21.53%
- Franchise has Short % of float of 21.62%
- Danimer Scientific has Short % of float of 21.68%
- Gossamer Bio has Short % of float of 21.70%